Nuclear Medicine/ Radiopharmaceuticals Market is Set to Boom by 2022

1
Nuclear Medicine/Radiopharmaceuticals Market
Opportunity Analysis and Industry Forecast,
2016-2023
Global Opportunity Analysis and Industry
Forecast, 2014-2022
2
Introduction of Nuclear Medicine/Radiopharmaceutic
als Market
Nuclear Medicine/Radiopharmaceuticals Market is
expected to garner 8,207.5 million by 2022. The
global radiopharmaceuticals market is poised to
grow at a significant pace, owing to growing
demand for non-invasive techniques, availability
of effective cancer treatment, and ability to
observe the functioning of the organ from outside
the body. Furthermore, increasing incidence of
cancer cardiovascular aliments, growing demand
for alpha radio immunotherapy-based targeted
cancer treatment, mounting call for nuclear
imaging techniques, and advancements in
radiotracers are expected to open new avenues in
the radiopharmaceuticals market. Factors that
are expected to drive the use of
radiopharmaceuticals include changing lifestyle,
elevated levels of stress, and ability to
identify various diseases sooner than other
diagnostic tests. However, factors such as supply
volatility logistical challenges, stringent
regulatory vigil, and competition from
conventional diagnostic procedures are
anticipated to impede the market growth.
3
Introduction of Nuclear Medicine/Radiopharmaceutic
als Market
Scope of
the Report
Key Benefits Key Audiences
4
 
Key Benefits

• Therapeutics segment is projected to be the
  fastest growing segment in the radiopharmaceutical
  s market, registering a CAGR of 16.9 from 2016
  to 2022.
• SPECT modality segment is expected to dominate
  the radiopharmaceuticals market in 2015 and
  expected to retain its position throughout the
  study period.
• Thyroid application segment is expected to
  exhibit double-digit CAGR of 11.
• Oncology application segment is expected to
  continue to lead the radiopharmaceuticals market,
  accounting for close to 60 share by 2022.
• Asia-Pacific is projected to be the fastest
  growing radiopharmaceuticals market, registering
  a CAGR of 8.4.

5
 
Table of Content (TOC)
Chapter 1 Introduction Chapter 2 Executive
Summary Chapter 3 Market Overview Chapter 4
World Radiopharmaceuticals Market, By Type,
2014-2022 Chapter 5 World Radiopharmaceuticals
Market, By Modality, 2014-2022 Chapter 6 World
Radiopharmaceuticals Market, By Application,
2014-2022 Chapter 7 World Radiopharmaceuticals
Market, By End-user, 2014-2022 Chapter 8 World
Radiopharmaceuticals Market, By Geography,
2014-2022 Chapter 9 Company Profiles
6
 
Segments Nuclear Medicine/Radiopharmaceuticals
Market
7
 
Segments Nuclear Medicine/Radiopharmaceuticals
Market
8

Segments Nuclear Medicine/Radiopharmaceuticals
Market
9

Segments Nuclear Medicine/Radiopharmaceuticals
Market
10
 
Company Profiles Nuclear Medicine/Radiopharmaceuti
cals Market

1. Mallinckrodt plc.
2. General Electric Co.
3. Medtronic, plc. (Covidien, acquired by Medtronic)
4. Bayer AG
5. Cardinal Health, Inc.
6. Lantheus Medical Imaging, Inc.

11
Thank You!
For More Details
Thank You Nuclear Medicine/Radiopharmaceuticals
Market
Do Enquiry
https//www.alliedmarketresearch.com/nuclear-medic
ine-radiopharmaceuticals-market
Follow Us On